Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands (Q35143528)

6 August 2017

title

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands (English)

1 reference

6 August 2017

0 references

Bart Hoogveldt

1

1 reference

6 August 2017

Benoît Rive

2

1 reference

6 August 2017

Johan Severens

3

1 reference

6 August 2017

Khaled Maman

4

1 reference

6 August 2017

Chantal Guilhaume

5

1 reference

6 August 2017

language of work or name

English

0 references

publication date

15 June 2011

1 reference

Neuropsychiatric Disease and Treatment

6 August 2017

published in

1 reference

6 August 2017

volume

7

1 reference

6 August 2017

page(s)

313-317

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

6 August 2017

copyright license

start time

1 June 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148924

Dementia-free life expectancy (DemFLE) in The Netherlands

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148924

Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148924

A Community-Based Study of Dementia: The Rotterdam Elderly Study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148924

Cost-effectiveness of memantine compared with standard care in moderate-to-severe Alzheimer disease in Canada

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148924

A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148924

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148924

Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148924

Memantine in moderate-to-severe Alzheimer's disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148924

Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148924

The cost of treatment of Alzheimer's disease in The Netherlands: a regression-based simulation model

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3148924

27 September 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21822384

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21822384

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/NDT.S19239

1 reference

6 August 2017

1 reference

6 August 2017

1 reference